Arbeitsgruppe Weichteilsarkome - Studien
| Advanced or metastatic soft tissue sarcoma, first and advanced treatment lines | ||||
| AIO-Studie | www.clinicaltrials.gov | zur Studie | ||
| AIO-STS-0415: A randomized phase II study of MEDI4736 and tremelimumab compared to doxorubicin in patients with advanced or metastatic soft tissue sarcoma. MEDISARC | ||||
| ---in Rekrutierung--- | ||||
| Weichteilsarkom - palliative Therapie, ab 1st line Derzeit keine aktuellen Studien |
| Weichteilsarkom – adjuvante Therapie Derzeit keine aktuellen Studien |
| Gastrointestinal stromal tumor (GIST) | ||||
| AIO-assoziierte Studie | www.clinicaltrials.gov | zur Studie | ||
| AIO-STS-0115/ass: Phase 2 trial of ponatinib in patients with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) following failure of prior therapy with imatinib (POETIG trial – POnatinib after rEsisTance to Imatinib in GIST) | ||||
| ---in Rekrutierung --- | ||||
| Gastrointestinal stromal tumor (GIST), adjuvante Therapie |
||||
| AIO-assoziierte Studie | www.clinicaltrials.gov | zur Studie | ||
| AIO-STS-0317/ass: Three versus five years of adjuvant imatinib as treatment of patients with operable GIST with a high risk for recurrence: A randomised phase III study |
||||
| ---in Rekrutierung --- | ||||
| Chordome, Knochensarkome, fortgeschrittene Erkrankung | ||||
| AIO-assoziierte Studie | www.clinicaltrials.gov | zur Studie | ||
| AIO-STS-0217/ass: CDK4/6 inhibition in locally advanced/metastatic chordoma - NCT-PMO-1601 | ||||
| ---in Rekrutierung --- | ||||
| Solide Tumore mit DNA-Reparatur Defizienz, fortgeschrittene Erkrankung | ||||
| AIO-assoziierte Studie | Für weitere Zentren offen | www.clinicaltrials.gov | zur Studie | |
| AIO-STS/TF-0117/ass: Randomized Phase-2 Study of Trabectedin/Olaparib Compared to Physician’s Choice in Subjects with Previously Treated Advanced or Recurrent Solid Tumors Harboring DNA Repair Deficiencies - NCT-PMO-1603 |
||||
| ---in Vorbereitung--- | ||||
| Rezidiviertes Sarkom / Registerstudie | ||||
| AIO-assoziierte Studie | Für weitere Zentren offen |
zur Studie | ||
| Sarcoma Relapse Registry for Relapsed Sarcoma of Bone and Soft Tissues (SAREZ = “SARkom REZidiv REgister”) ---in Rekrutierung--- Einladung zur Teilnahme an der Studie hier Antwortfax hier Studien der IAWS hier |
||||
| AIO-assoziierte Studie | zur Studie | |||
| Registry for primary and secondary angio- and radiation-induced Sarcoma of Bone and Soft Tissues (RIS) (ANGRY = “ANGio- and Radiation-induced sarcoma registrY”) | ||||
| ---in Rekrutierung--- | ||||
| Retrospektive Analyse | ||||
| AIO-assoziierte Studie | Für weitere Zentren offen | zur Studie | ||
| AIO-STS-0116/ass: Retrospektive Analyse zur Wirksamkeit der Kombinationstherapie aus Temozolomid plus Avastin im Vergleich zu alternativen Systemtherapien bei Patienten mit Solitär Fibrösem Tumor. | ||||
| LETZTE AKTUALISIERUNG DIESER SEITE AM:15.07.2018 |